Sharing Management of COVID-19 in America as well as Public Health Centers and Primary Clinics in Indonesia

https://doi.org/10.22146/rpcpe.65665

Siti Marlina(1*), Hari Kusnanto(2), Mark Alan Graber(3)

(1) Puskesmas Bantul II; Indonesia
(2) Department of Family and Community Medicine; Faculty of Medicine, Public Health, and Nursing; Universitas Gadjah Mada
(3) Department of Family Medicine; University of Iowa; USA
(*) Corresponding Author

Abstract


Since the Coronavirus-2019 (COVID-19) was declared by the World Health Organization (WHO) as a pandemic on March 11, 2020, and then Indonesia declared COVID-19 a national disaster on March 14, 2020, COVID-19 cases in Indonesia and the world have increased rapidly. Puskesmas and clinics are at the forefront of handling and preventing the transmission of COVID-19. Puskesmas and clinics must prepare their own resources and service protocols in order to serve the community without neglecting the safety and health of patients and health workers from the risk of transmission of COVID-19. Health workers meet with patients and visitors to health facilities every day, sometimes even with inadequate personal protective equipment (PPE), so they are very much at risk of being exposed to COVID-19, from patients or vice versa. With the increase in COVID-19 cases, a comprehensive effort is needed in case management and efforts to break the chain of transmission and keep health workers protected in conducting their duties. Modification of health service facilities in Puskesmas and clinics, changes in service flow, standard operating procedures for health services must be adjusted by paying attention to the safety of health workers and patients/visitors to avoid COVID-19 transmission. Preparedness of Puskesmas and clinics in facing the COVID-19 pandemic should be done by strict management according to the patient's condition by paying attention to PPE principles, conducting strict surveillance of suspected and positive COVID-19 cases, case reporting system within 1x 24 hours to the District/City Health Office, conducting epidemiology investigations and providing risk communication to the community as well as improving networks with stakeholders, across sectors and local community leaders.


Full Text:

PDF


References

1. Ministry of Health, Republic of Indonesia. Guidelines for the prevention and control of coronavirus disease (Covid-19) 4th revision. Jakarta: Ministry of Health, Republic of Indonesia; 2020.

2. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843-4.

3. Chen C, Gao G, Xu Y, Pu L, Wang Q, Wang L, et al. SARS- CoV-2– positive sputum and feces after conversion of pharyngealsamples in patients with COVID-19. Annals of Internal Medicine. 2020;172(12):832-4. doi: 10.7326/M20-0991

4. Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circulation Research. 2020;126(12):1671-81. doi: 10.1161/CIRCRESAHA.120.317134

5. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. Atrial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. NEngl J Med. 2020;382:1787-1799.

6. Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323(16):1582-1589. doi: 10.1001/jama.2020.4783.



DOI: https://doi.org/10.22146/rpcpe.65665

Article Metrics

Abstract views : 504 | views : 457

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Siti Marlina, Hari Kusnanto, Mark Alan Graber

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


View My Stats